Compared with patients without heart failure, novel biomarker levels for MR-proADM and MR-proANP were statistically significantly higher in both LVSD (p = 0.013, p = 0.001 respectively) and HFpEP (p = 0.022, p = 0.001 respectively) groups. Here, NPPA is linked to heart failure.